# Dole

Type: Company (DOLE)

Source: Healthcare Intelligence Brief — https://gethealthbrief.com/entity/dole
Canonical HTML page: https://gethealthbrief.com/entity/dole

## Timeline

- **2026-12-31**: FY26 Target — Target date for achieving long-term Adjusted EBITDA margin goals set in the outlook.
- **2026-Q2**: Operational Milestone — Expected completion of key back-office automation initiatives to drive margin growth.
- **2026-02-25**: Earnings Release — Company reports Q4 results and introduces the FY26 strategic outlook.
- **2025-12-31**: Q4 Period End — LifeStance concludes its fiscal fourth quarter with a focus on clinician productivity.

## Recent coverage (1 stories)

### LifeStance Health Signals Long-Term Stability with Multi-Year FY26 Outlook
2026-02-25 11:19:30 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

LifeStance Health Group reported its fourth-quarter results for 2025, concurrently issuing a strategic financial outlook for fiscal year 2026. The company is pivoting from aggressive footprint expansion toward margin optimization and clinician retention as it targets long-term profitability.
Full story: https://gethealthbrief.com/story/lifestance-health-q4-earnings-fy26-outlook

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://gethealthbrief.com/guides/methodology for the full editorial methodology.